VIM-positive Pseudomonas aeruginosa - the pre-SAMPAN study.

Detection of Verona Integron-encoded Metallo-ß-lactamase (VIM)-positive Pseudomonas aeruginosa strains from different body sites: the pre-SAMPAN study.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24069

Enrollment

Registered

2021-08-17

Start date

2021-08-17

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VIM-positive Pseudomonas aeruginosa carriage

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: All living patients aged >18 years old, known to be carrying VIM-PA or formerly carrying VIM-PA, with a signed consent sheet.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: no informed consent.

Design outcomes

Primary

Measure	Time frame
The main study endpoint is finding positive body sites of VIM-positive P. aeruginosa, other than the standard surveillance culture sites.	—

Secondary

Measure	Time frame
Secondary endpoints are patient characteristics favouring specific body sites being colonized by VIM-positive Pseudomonas aeruginosa.	—

Contacts

Public ContactDr. Juliëtte A. Severin

Erasmus MC University Medical Center

j.severin@erasmusmc.nl010 70 34188

Outcome results